Skip Navigation

A Phase II/III Randomized, Open-Label Study of Maintenance GRT-C901/GRT-R902, A Neoantigen Vaccine, in Combination with Immune Checkpoint Blockade for Patients with Metastatic Colorectal Cancer

Brief Summary

Type:
Colorectal

Study Type:
Treatment

Phase:
II/III

ClinicalTrials.gov Identifier:
NCT05141721

Study #:
STUDY00149111

Start Date:
Mar 13, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05141721

View Complete Trial Details & Eligibility at ClinicalTrials.gov